Microencapsulation of mildronate in biodegradable and non-biodegradable polymers

References

• Anderson PP, Astapenko EB, Eremeev A, Giller SA, Kalvinsh IY, Latvietis YY, Liepinsh EE, Podoprigora GI, Semenikhina VG, Spruzh YY, et al. 3-(2,2,2-Trimethylhydrazinium)propionate and method for the preparation and use thereof. US 4481218 (A), 1984
   Google Scholar
• Berchane NS, Carson KH, Rice-Ficht AC, Andrews MJ. Effect of mean diameter and polydispersity of PLG microspheres on drug release: Experiment and theory. Int J Pharm, 2007;337:118–26
   PubMed Web of Science ®Google Scholar
• Chen JL, Chiang CH, Yeh MK. The mechanism of PLA microparticle formation by water-in-oil-in-water solvent evaporation method. J Microencapsulation, 2002;19:333–46
   PubMed Web of Science ®Google Scholar
• Cheow W, Hadinoto K. Enhancing encapsulation efficiency of highly water-soluble antibiotic in poly(lactic-co-glycolic acid) nanoparticles: Modifications of standard nanoparticle preparation methods. Colloids Surfaces A: Physicochem Eng Aspects, 2010;370:79–86
   Web of Science ®Google Scholar
• Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm, 2004;282:1–18
   PubMed Web of Science ®Google Scholar
• Freitas S, Merkle FK, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation process technology. J Controlled Release, 2005;102:313–32
   PubMed Web of Science ®Google Scholar
• Giri TK, Choudhary C, Ajazuddin, Alexander A, Badwaik H, Tripathi DK. Prospects of pharmaceuticals and biopharmaceuticals loaded microparticles prepared by double emulsion technique for controlled delivery. Saudi Pharmaceutical J, 2013;21:125--41
   Google Scholar
• Hino T, Shimabawashi S, Tanaka M, Nakano M, Okochi K. Improvement of encapsulation efficiency of water-in-oil-in-water emulsion with hypertonic inner aqueous phase. J Microencapsulation, 2001;18:19–28
   PubMed Web of Science ®Google Scholar
• Kuka J, Vilskersts R, Cirule H, Makrecka M, Pugovics O, Kalvinsh I, Dambrova M, Liepinsh E. The cardioprotective effect of mildronate is diminished after co-treatment with l-carnitine. J Cardiovasc Pharmacol Ther, 2012;7:215–22
   Google Scholar
• Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm, 2008;363:26–39
   PubMed Web of Science ®Google Scholar
• Liepins E, Vilskersts R, Loca D, Kirjanova O, Pugovichs O, Kalvinsh I, Dambrova M. Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction. J Cardiovasc Pharmacol, 2006;48:314–19
   PubMedGoogle Scholar
• Liepinsh E, Skapare E, Svalbe B, Makrecka M, Cirule H, Dambrova M. Anti-diabetic effects of mildronate alone or in combination with metformin in obese Zucker rats. Eur J Pharmacol, 2011;658:277–83
   PubMedGoogle Scholar
• Majeti NV, Kumar R. Nano and microparticles as controlled drug delivery devices. J Pharm Pharmaceut Sci, 2000;3:234–58
   PubMed Web of Science ®Google Scholar
• Mandal TK, Bostanian LA, Graves RA, Chapman SR. Poly(d,l-lactide-co-glycolide) encapsulated poly(vinyl alcohol) hydrogel as a drug delivery system. Pharm Res, 2002;19:1713–19
   PubMed Web of Science ®Google Scholar
• Mani N, Jun HW. Microencapsulation of a hydrophylic drug into a hydrophobic matrix using a salting-out procedure. I: Development and optimization of the process using factorial design. J Microencapsulation, 2004;21:125–35
   PubMed Web of Science ®Google Scholar
• O’Donnell PB, McGinity JW. Preparation of michrospheres by the solvent evaporation technique. Adv Drug Deliv Rev, 1997;28:25–42
   PubMed Web of Science ®Google Scholar
• Ozalp Y, Ozdemir N, Kocagoz S. Controlled release of vancomycin from biodegradable microcapsules. J Microencapsulation, 2001;18:89–10
   PubMedGoogle Scholar
• Parikh RH, Parikh JR, Dubey RR, Soni HN, Kapadia KN. Poly(d,l-lactide-co-glycolide) microspheres containing 5-fluorouracil: optimization of process parameters. AAPS PharmSciTech, 2003;4:14--21
   Google Scholar
• Peltonen L, Aitta J, Karjalainen M, Hyvönen S, Hirvonen J. Improved entrapment efficiency of hydrophylic drug substance during nanoprecipitation of poly(I)lactide nanoparticles. AAPS PharmSciTech, 2004;5:115--20
   Web of Science ®Google Scholar
• Peng Y, Yang J, Wang Z, Wang J, Liu Y, Luo Z, Wen A. Determination of mildronate by LC–MS/MS and its application to a pharmacokinetic study in healthy Chinese volunteers. J Chromatogr B, 2010;878:551–6
   PubMedGoogle Scholar
• Pistel KF, Kissel T. Effect of salt addition on the microencapsulation of proteins using w/o/w double emulsion technique. J Microencapsulation, 2000;17:467–83
   PubMed Web of Science ®Google Scholar
• Pupure J, Isajevs S, Skapare E, Rumaks J, Svirskis S, Svirina D, Kalvinsh I, Klusa V. Neuroprotective properties of mildronate, a mitochondria-targeted small molecule. Neurosci Lett, 2010;470:100–5
   PubMedGoogle Scholar
• Ruan G, Ng JK, Feng SS. Effects of polymer, organic solvent and mixing strength on integrity of proteins and liposomes encapsulated in polymeric microspheres fabricated by double emulsion process. J Microencapsulation, 2004;21:399–12
   PubMed Web of Science ®Google Scholar
• Sher P, Ingavle G, Ponrathnam S, Pawar AP. Low density porous carrier drug adsorption and release study by response surface methodology using different solvents. Int J Pharm, 2007;331:72–83
   PubMedGoogle Scholar
• Silva JPS, Ferreira JPM. Effect of drug properties on release from CAP microspheres prepared by a solvent evaporation method. J Microencapsulation, 1999;16:95–103
   PubMed Web of Science ®Google Scholar
• Tan H, Ye J. Surface morphology and in vitro release performance of double-walled PLLA/PLGA microspheres entrapping a highly water-soluble drug. Appl Surf Sci, 2008;255:353–6
   Web of Science ®Google Scholar
• Watts PJ, Davies MC, Melia CD. Microencapsulation using emulsification/solvent evaporation: an overview of techniques and applications. Crit Rev Ther Drug, 1990;7:235–59
   PubMed Web of Science ®Google Scholar
• Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Controlled Release, 2010;146:241–60
   PubMed Web of Science ®Google Scholar
• Yeh MK, Chen JL, Chiang CH. Vibrio cholerae-loaded poly(dl lactide co-glycolide) microparticles. J Microencapsulation, 2002;19:203–12
   PubMed Web of Science ®Google Scholar
• Yoshisue K, Yamamoto Y, Yoshida KI, Saeki M, Minami Y, Esumi Y, Kawaguchi Y. Pharmacokinetics and Biological Fate of 3-(2,2,2-Trimethylhydrazinium)Propionate Dihydrate (MET-88), a novel cardioprotective agent, in rats. Drug Metab Dispos, 2000;28:687–94
   PubMedGoogle Scholar
• Zhang Y, Chan HF, Leong KW. Advanced materials and processing for drug delivery: The past and the future. Adv Drug Deliv Rev, 2013;65:104--20
   Google Scholar
• Zhu KJ, Jiang HL, Du XY, Wang J, Xu WX, Liu SF. Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent evaporation technique. J Microencapsulation, 2001;18:247–60
   PubMed Web of Science ®Google Scholar